Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.
Single Subject Studies in Prostate Cancer: How graphing PSA test results and testosterone levels using Process Behavior and Celeration Charts can provide insight and guide clinical decisions
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
Changes in specific serum biomarkers during the induction of prostatic hyperplasia in dogs | BMC Veterinary Research | Full Text
Solved May you please use a joint probability table to solve | Chegg.com
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice. - Abstract - Europe PMC
Cancers | Free Full-Text | The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological Outcomes
Stacy Loeb, MD on Twitter: "PSA decreased below the threshold for biopsy in 46% of men who made lifestyle changes (no spicy food, alcohol, caffeine or cycling for >8 weeks) before repeat
Detection of prostate specific antigen (PSA) in human saliva using an ultra-sensitive nanocomposite of graphene nanoplatelets with diblock-co-polymers and Au electrodes - Analyst (RSC Publishing)
Low detectable PSA after prostatectomy – watch or treat? | THE "NEW" PROSTATE CANCER INFOLINK
3M Lapping Film 869XW, 0.02 Micron PSA Disc, 1.865 in x .102 in, 3M 3M869XW, 60-0200-2028-9 | Hillas.com
Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis
PSA Testing | ZERO Prostate Cancer
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
6.3.Management of PSA-only recurrence after treatment with curative intent
Pretreatment Predictors of Time to Cancer Specific Death After Prostate Specific Antigen Failure | Journal of Urology
